Mirtazapine: a review of its clinical efficacy and tolerability.
Szegedi
Armin
A
Department of Psychiatry, Charité-University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, D-14050 Berlin, Germany. armin.szegedi@charite.de
Schwertfeger
Natascha
N
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000523:psychology; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use
D000928:Antidepressive Agents; D012702:Serotonin Antagonists; D008803:Mianserin; D000078785:Mirtazapine